Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

OXIS completes preclinicals of restenosis treatment

March 7, 1997

Watson's mexiletine approved

March 6, 1997

Dual NEP/ECE inhibitor for heart failure

March 6, 1997

Potential agent for hypertension and CHF from Roche Bioscience

March 6, 1997

Zeneca presents potent and selective ETA receptor antagonist

March 6, 1997

Senju prepares beta-blocker

March 6, 1997

Lp-PLA2 inhibitors disclosed by SKB

March 5, 1997

ET antagonists from Warner-Lambert

March 5, 1997

Antiarrhythmic agents reported by National Science Council

March 4, 1997

Preliminary phase II data on Xoma's Neuprex in trauma

March 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...